ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

“You Can’t Legislate Biology,” Higginson Tells AACI Members

February 9, 1979

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007

Clearinghouse Funds Two Carcinogens And A Threat To Humans

March 17, 1978

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993

In Brief: Korsmeyer Wins Bristol-Meyers Squibb Award; Lichter Names President-Elect of ASCO

April 18, 1997

Institute of Medicine Elects 70 Members at Annual Meeting

October 25, 2013